Nursing Assessment of Pressure Injury Risk with the Braden Scale Validated against Sensor-Based Measurement of Movement
Abstract
:1. Introduction
2. Methods
2.1. Design, Sample, and Setting
2.2. Measures
2.2.1. Braden Scale and Subscales
- Mobility subscale—“ability to change and control body position” (p. 8), moving while lying or reclining in bed or chair;
- Activity subscale—ability to release pressure from or “avoid intense and prolonged pressure over vulnerable skin areas” (p. 8) and indicates how much or how little the resident moves independently while out of bed or in a wheelchair;
- Sensory Perception subscale—“ability to perceive or respond to discomfort by changing position or requesting assistance to change position” (p. 9)
2.2.2. Repositioning Movement
- Upright position—≥50 degrees upright angle of resident’s torso to ground when standing or sitting in bed or chair. Tilt angle ≥ 10 degrees signified a hip-to-hip weight shift to right or left while upright.
- Lying position—<50 degrees upright angle of resident’s torso to ground when facing upward. Roll angle ≥20 degrees signified a left or right change in position while lying.
- Ambulating position—≥9 steps of forward movement within the resident’s room or other location at NH.
2.3. Statistical Analysis
3. Results
3.1. Mobility and Activity Subscale Results
3.1.1. Mobility Subscale Results
3.1.2. Activity Subscale Results
3.2. Mobility, Activity, and Sensory Perception Subscale Association Results
4. Discussion
Limitations
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Padula, W.V.; Delarmente, B.A. The National Cost of Hospital-Acquired Pressure Injuries in the United States. Int. Wound J. 2019, 16, 634–640. [Google Scholar] [CrossRef] [PubMed]
- European Pressure Ulcer Advisory Panel, National Pressure Injury Advisory Panel and Pan Pacific Pressure Injury Alliance. Prevention and Treatment of Pressure Ulcers/Injuries: Clinical Practice Guideline. The International Guideline. 3rd Edition. Emily Haesler (Ed.). EPUAP/NPIAP/PPPIA: 2019.
- Bergstrom, N.; Braden, B.J.; Laguzza, A.; Holman, V. The Braden Scale for Predicting Pressure Sore Risk. Nurs. Res. 1987, 36, 205–210. [Google Scholar] [CrossRef] [PubMed]
- The Braden Scale. Available online: https://www.in.gov/health/files/Braden_Scale.pdf (accessed on 1 September 2022).
- Braden, B.J.; Bergstrom, N. Clinical utility of the Braden scale for Predicting Pressure Sore Risk. Decubitus 1989, 2, 44–51. [Google Scholar] [PubMed]
- Braden, B.J.; Bergstrom, N. Predictive validity of the Braden Scale for pressure sore risk in a nursing home population. Res. Nurs. Health 1994, 17, 459–470. [Google Scholar] [CrossRef] [PubMed]
- Kottner, J.; Balzer, K. Do pressure ulcer risk assessment scales improve clinical practice? J. Multidiscip. Healthc. 2010, 3, 103–111. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bergstrom, N.; Braden, B.; Kemp, M.; Champagne, M.; Ruby, E. Predicting pressure ulcer risk: A multisite study of the predictive validity of the Braden Scale. Nurs. Res. 1998, 47, 261–269. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bergstrom, N.; Demuth, P.; Braden, B. A clinical trial of the Braden Scale for predicting pressure sore risk. Nurs. Clin. N. Am. 1987, 22, 417–428. [Google Scholar] [CrossRef]
- Anthony, D.; Papanikolaou, P.; Parboteeah, S.; Saleh, M. Do risk assessment scales for pressure ulcers work? J. Tissue Viability 2010, 19, 132–136. [Google Scholar] [CrossRef] [PubMed]
- By the numbers: Braden Score interventions. Adv. Skin Wound Care 2004, 17, 150. [CrossRef] [PubMed]
- Ayello, E.A.; Baranoski, S.; Lyder, C.H.; Cuddigan, J. Pressure ulcers. In Wound Care Essentials: Practice Principles; Baranoski, S., Ayello, E.A., Eds.; Lippincott Williams & Wilkins: Springhouse, PA, USA, 2004; pp. 240–270. [Google Scholar]
- Catania, K.; Huang, C.; James, P.; Madison, M.; Moran, M.; Ohr, M. Wound wise: PUPPI: The Pressure Ulcer Prevention Protocol Interventions. Am. J. Nurs. 2007, 107, 44–52. [Google Scholar] [CrossRef] [PubMed]
- Braden, B.; Bergstrom, N. A conceptual schema for the study of the etiology of pressure sores. Rehabil. Nurs. 1987, 12, 8–12. [Google Scholar] [CrossRef] [PubMed]
- Bergstrom, N.; Braden, B.; Norvell, K.; Lenaghan, P.; Boynton, P. Diminished tissue tolerance: Influence on pressure sore development in the institutionalized elderly. Appl. Nurs. Res. 1988, 1, 96. [Google Scholar] [CrossRef]
- Yap, T.L.; Horn, S.D.; Sharkey, P.D.; Zheng, T.; Bergstrom, N.; Colon-Emeric, C.; Sabol, V.K.; Alderden, J.; Yap, W.; Kennerly, S.M. Effect of Varying Repositioning Frequency on Pressure Injury Prevention in Nursing Home Residents: TEAM-UP Trial Results. Adv. Skin Wound Care 2022, 35, 315–325. [Google Scholar] [CrossRef] [PubMed]
- SAS Institute Inc. SAS/STAT® 15.2 (Version SAS® 9.4M7) [Computer Software]; SAS Institute Inc.: Cary, NC, USA, 2013. [Google Scholar]
- Cohen, J. Statistical Power Analysis for the Behavioral Sciences, 2nd ed.; Lawrence Erlbaum Associates: Hillsdale, NJ, USA, 1988. [Google Scholar]
- Defloor, T.; Grypdonck, M.F. Validation of pressure ulcer risk assessment scales: A critique. J. Adv. Nurs. 2004, 48, 613–621. [Google Scholar] [CrossRef] [PubMed]
- Lim, E.; Mordiffi, Z.; Chew, H.S.J.; Lopez, V. Using the Braden subscales to assess risk of pressure injuries in adult patients: A retrospective case-control study. Int. Wound J. 2019, 16, 665–673. [Google Scholar] [CrossRef] [PubMed]
- Park, S.H.; Lee, H.S. Assessing Predictive Validity of Pressure Ulcer Risk Scales- A Systematic Review and Meta-Analysis. Iran J. Public Health 2016, 45, 122–133. [Google Scholar]
Characteristic | Total Sample |
---|---|
Age in Years mean (SD) | 77.7 (13.1) |
Age Distribution N (%) | |
≤64 years | 153 (16.8) |
65–70 years | 110 (12.1) |
71–80 years | 216 (23.6) |
81–85 years | 126 (13.8) |
86–89 years | 115 (12.6) |
≥90 years | 193 (21.1) |
Gender: Male N (%) | 349 (38.2) |
Race ∬ N (%) | |
Black | 260 (28.5) |
White | 598 (65.5) |
Other | 55 (6.0) |
Ethnicity N (%) | |
Hispanic or Latino | 21 (2.3) |
Not Hispanic or Latino | 892 (97.7) |
Top Diagnoses N (%) | |
Difficulty walking | 779 (85.3) |
Muscle weakness/wasting | 747 (81.8) |
Difficulty with swallowing or speech | 502 (55.0) |
Hypertension | 429 (47.0 |
Atherosclerotic heart disease | 280 (30.7) |
Alzheimer’s disease & related dementias | 450 (49.3) |
Gastroesophageal reflux disease (GERD) | 273 (29.9) |
Depression | 213 (23.3) |
Diabetes, Type 2 | 197 (21.6) |
Cerebrovascular disease | 190 (20.8) |
Braden Scale Scores mean (SD) | |
Mobility | 3.0 (0.8) |
Activity | 2.5 (0.8) |
Sensory Perception | 3.7 (0.6) |
Total Braden Score | 17.5 (3.0) |
Movement Features mean (SD) | |
MEAN Lying Duration (min)/Day | 897.9 (264.8) |
MEAN Lying Frequency/Day | 105.6 (87.3) |
MEAN Upright Duration (min)/Day | 477.6 (261.3) |
MEAN Upright Frequency/Day | 221.0 (175.0) |
Total Ambulating Duration (min)/Day | 25.5 (51.6) |
Total Ambulating Frequency/Day | 7.3 (11.2) |
Braden Mobility Subscale Score § | Pairwise Comparisons | ANOVA | ||||||
---|---|---|---|---|---|---|---|---|
Movement Features | 1 (n = 28) | 2 (n = 236) | 3 (n = 349) | 4 (n = 300) | Subgroups | Mean Difference | F | p |
MEAN Lying Duration | 1149.4 | 1024.5 | 874.6 | 801.8 | 1–2 | 124.9 | 46.56 | <0.001 |
(min)/Day mean (SD) | (276.2) | (270.7) | (242.8) | (228.7) | 1–3 | 274.8 * | ||
1–4 | 347.7 * | |||||||
2–3 | 149.9 * | |||||||
2–4 | 222.8 * | |||||||
3–4 | 72.9 * | |||||||
MEAN Lying | 116.0 | 100.0 | 109.4 | 104.5 | 1–2 | 16.0 | 0.67 | 0.568 |
Frequency/Day mean (SD) | (127.9) | (73.0) | (95.2) | (85.2) | 1–3 | 6.6 | ||
1–4 | 11.5 | |||||||
2–3 | 9.3 | |||||||
2–4 | 4.5 | |||||||
3–4 | 4.8 | |||||||
MEAN Upright Duration | 236.7 | 361.5 | 507.8 | 556.2 | 1–2 | 124.9 | 38.22 | <0.001 |
(min)/Day mean (SD) | (281.7) | (269.2) | (242.6) | (228.6) | 1–3 | 271.1 * | ||
1–4 | 319.5 * | |||||||
2–3 | 146.2 * | |||||||
2–4 | 194.6 * | |||||||
3–4 | 48.4 | |||||||
MEAN Upright | 69.6 | 117.6 | 228.8 | 307.5 | 1–2 | 48.0 | 73.2 | <0.001 |
Frequency/Day mean (SD) | (96.9) | (135.7) | (166.2) | (166.5) | 1–3 | 159.2 * | ||
1–4 | 238.0 * | |||||||
2–3 | 111.2 * | |||||||
2–4 | 190.0 * | |||||||
3–4 | 78.8 * |
Braden Activity Subscale Score § | Pairwise Comparisons | ANOVA | ||||||
---|---|---|---|---|---|---|---|---|
Movement Features | 1 (n = 58) | 2 (n = 463) | 3 (n = 259) | 4 (n = 133) | Subgroups | Mean Difference | F | p |
MEAN Lying Duration | 1219.9 | 934.4 | 816.7 | 788.3 | 1–2 | 285.5 * | 55.75 | <0.001 |
(min)/Day mean (SD) | (192.1) | (265.0) | (233.6) | (202.0) | 1–3 | 403.2 * | ||
1–4 | 431.6 * | |||||||
2–3 | 117.7 * | |||||||
2–4 | 146.1 * | |||||||
3–4 | 28.4 | |||||||
MEAN Lying | 146.1 | 105.3 | 102.4 | 94.9 | 1–2 | 40.8 * | 4.94 | 0.002 |
Frequency/Day mean (SD) | (115.8) | (88.4) | (87.9) | (64.6) | 1–3 | 43.7 * | ||
1–4 | 51.2 * | |||||||
2–3 | 2.9 | |||||||
2–4 | 10.4 | |||||||
3–4 | 7.5 | |||||||
MEAN Upright Duration | 166.7 | 450.3 | 561.7 | 544.2 | 1–2 | 283.5 * | 47.08 | <0.001 |
(min)/Day mean (SD) | (191.8) | (263.2) | (235.0) | (204.6) | 1–3 | 395.0 * | ||
1–4 | 377.5 * | |||||||
2–3 | 111.4 * | |||||||
2–4 | 94.0 * | |||||||
3–4 | 17.5 | |||||||
MEAN Upright | 58.2 | 178.6 | 283.1 | 318.9 | 1–2 | 120.4 * | 60.40 | <0.001 |
Frequency/Day mean (SD) | (117.7) | (164.6) | (166.1) | (147.1) | 1–3 | 224.8 * | ||
1–4 | 260.7 * | |||||||
2–3 | 104.5 * | |||||||
2–4 | 140.3 * | |||||||
3–4 | 35.8 | |||||||
TOTAL Ambulating Duration | 1.0 | 11.4 | 32.2 | 72.4 | 1–2 | 10.5 | 65.23 | <0.001 |
(min)/Day mean (SD) | (3.9) | (38.1) | (42.1) | (81.2) | 1–3 | 31.2 * | ||
1–4 | 71.4 * | |||||||
2–3 | 20.7 * | |||||||
2–4 | 60.9 * | |||||||
3–4 | 40.2 * | |||||||
TOTAL Ambulating | 0.4 | 3.3 | 10.2 | 18.3 | 1–2 | 2.9 | 99.98 | <0.001 |
Frequency/Day mean (SD) | (1.3) | (8.1) | (8.6) | (16.5) | 1–3 | 9.8 * | ||
1–4 | 17.9 * | |||||||
2–3 | 6.8 * | |||||||
2–4 | 14.9 * | |||||||
3–4 | 8.1 * |
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ||
---|---|---|---|---|---|---|---|---|---|---|
Variable | Mobility Subscale | Activity Subscale | Sensory Perception | Lying Duration | Lying Frequency | Upright Duration | Upright Frequency | Ambulating Duration | Ambulating Frequency | |
1 | Mobility Subscale | 1.00 | ||||||||
2 | Activity Subscale | 0.64 *** | 1.00 | |||||||
3 | Sensory Perception Subscale | 0.44 *** | 0.33 *** | 1.00 | ||||||
4 | MEAN Lying Duration (min)/Day | −0.36 *** | −0.35 *** | −0.20 *** | 1.00 | |||||
5 | MEAN Lying Frequency/Day | 0.01 | −0.09 ** | −0.02 | 0.26 *** | 1.00 | ||||
6 | MEAN Upright Duration (min)/Day | 0.32 *** | 0.30 *** | 0.18 *** | −0.98 *** | −0.23 *** | 1.00 | |||
7 | MEAN Upright Frequency/Day | 0.44 *** | 0.39 *** | 0.27 *** | −0.68 *** | 0.12 *** | 0.67 *** | 1.00 | ||
8 | TOTAL Ambulating Duration (min)/Day | 0.32 *** | 0.41 *** | 0.20 *** | −0.29 *** | −0.06 * | 0.14 *** | 0.28 *** | 1.00 | |
9 | TOTAL Ambulating Frequency/Day | 0.40 *** | 0.49 *** | 0.23 *** | −0.37 *** | −0.06 | 0.24 *** | 0.39 *** | 0.87 *** | 1.00 |
Movement Feature | Braden Subscale * | B | p | R2 |
---|---|---|---|---|
MEAN Lying Duration (min)/Day | Mobility1 | 191.23 | <0.001 | 0.189 |
Mobility2 | 132.97 | <0.001 | ||
Mobility3 | 39.34 | 0.076 | ||
Activity1 | 302.56 | <0.001 | ||
Activity2 | 64.48 | 0.029 | ||
Activity3 | 6.62 | 0.808 | ||
Sensory Perception2 | 37.49 | 0.340 | ||
Sensory Perception3 | 15.91 | 0.427 | ||
MEAN Lying Frequency/Day | Mobility1 | −23.42 | 0.227 | 0.025 |
Mobility2 | −26.24 | 0.010 | ||
Mobility3 | −5.36 | 0.507 | ||
Activity1 | 69.85 | <0.001 | ||
Activity2 | 22.52 | 0.036 | ||
Activity3 | 10.22 | 0.303 | ||
Sensory Perception2 | 6.86 | 0.631 | ||
Sensory Perception3 | 2.46 | 0.736 | ||
MEAN Upright Duration | Mobility1 | −184.41 | <0.001 | 0.167 |
(min)/Day | Mobility2 | −125.06 | <0.001 | |
Mobility3 | −32.51 | 0.143 | ||
Activity1 | −256.04 | <0.001 | ||
Activity2 | −18.88 | 0.523 | ||
Activity3 | 35.93 | 0.188 | ||
Sensory Perception2 | −38.09 | 0.332 | ||
Sensory Perception3 | −12.84 | 0.521 | ||
Mean Upright Frequency/Day | Mobility1 | −138.19 | <0.001 | 0.231 |
Mobility2 | −121.95 | <0.001 | ||
Mobility3 | −48.92 | <0.001 | ||
Activity1 | −141.35 | <0.001 | ||
Activity2 | −57.48 | 0.003 | ||
Activity3 | −9.64 | 0.583 | ||
Sensory Perception2 | −62.47 | 0.014 | ||
Sensory Perception3 | −24.06 | 0.062 | ||
TOTAL Ambulating Duration (min)/Day | Activity1 | −66.66 | <0.001 | 0.183 |
Activity2 | −57.80 | <0.001 | ||
Activity3 | −39.27 | <0.001 | ||
Sensory Perception2 | −9.72 | 0.187 | ||
Sensory Perception3 | −9.28 | 0.015 | ||
TOTAL Ambulating Frequency/Day | Activity1 | −16.94 | <0.001 | 0.253 |
Activity2 | −14.30 | <0.001 | ||
Activity3 | −7.91 | <0.001 | ||
Sensory Perception2 | −2.73 | 0.073 | ||
Sensory Perception3 | −1.53 | 0.053 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Kennerly, S.M.; Sharkey, P.D.; Horn, S.D.; Alderden, J.; Yap, T.L. Nursing Assessment of Pressure Injury Risk with the Braden Scale Validated against Sensor-Based Measurement of Movement. Healthcare 2022, 10, 2330. https://doi.org/10.3390/healthcare10112330
Kennerly SM, Sharkey PD, Horn SD, Alderden J, Yap TL. Nursing Assessment of Pressure Injury Risk with the Braden Scale Validated against Sensor-Based Measurement of Movement. Healthcare. 2022; 10(11):2330. https://doi.org/10.3390/healthcare10112330
Chicago/Turabian StyleKennerly, Susan M., Phoebe D. Sharkey, Susan D. Horn, Jenny Alderden, and Tracey L. Yap. 2022. "Nursing Assessment of Pressure Injury Risk with the Braden Scale Validated against Sensor-Based Measurement of Movement" Healthcare 10, no. 11: 2330. https://doi.org/10.3390/healthcare10112330